Ang, Yuen-Siang http://orcid.org/0000-0002-9353-6837
Pizzagalli, Diego A.
Funding for this research was provided by:
Agency for Science, Technology and Research, Singapore (National Science Scholarship)
Harvard Medical School (Kaplen Fellowship in Depression)
National Institute of Mental Health (R37MH068376)
Article History
Accepted: 28 December 2020
First Online: 11 January 2021
Compliance with ethical standards
:
: Over the past 3 years, Dr. Diego Pizzagalli has received consulting fees from BlackThorn Therapeutics, Boehringer Ingelheim, Compass Pathway, Engrail Therapeutics, Otsuka Pharmaceuticals, and Takeda Pharmaceuticals as well as one honorarium from Alkermes. In addition, he has received stock options from BlackThorn Therapeutics and research support from National Institute of Mental Health, Dana Foundation, Brain and Behavior Research Foundation, and Millennium Pharmaceuticals. No funding from these entities was used to support the current work, and all views expressed are solely those of the authors. Dr. Ang declares that he has no conflict of interest.
: The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.